Intech Biopharm Corporation (TPEX:6461)
18.20
+0.15 (0.83%)
Apr 29, 2026, 11:08 AM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.22 billion as of April 28, 2026. Its market cap has increased by 7.58% in one year.
Market Cap
3.22B
Enterprise Value
4.19B
Revenue
107.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.20
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.22B, a decrease of -19.59%. That is a compound annual growth rate of -1.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.17B |
| Shine-On BioMedical | 3.27B |
| SYN-TECH Chem. & Pharm. | 3.16B |
| BRIM Biotechnology | 3.06B |
| HeXun Biosciences | 2.96B |
| BioGend Therapeutics | 3.61B |
| Apex Biotechnology | 2.87B |
| TWi Biotechnology | 2.84B |